Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-24-023373

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 50,852 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jacobson Mark L. · CHIEF OPERATING OFFICER

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-27 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +32,825 32,825 D
2024-02-27 Grant or award : show line 2 in the form Restricted Stock Units +18,027 18,027 D
Loading xslF345X05/ownership.xml…